Clinical trial

Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women

NCT02584140

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BEHAVIORAL · Unmapped registry intervention Text Messaging Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Adherence Counseling Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Daily Oral PrEP Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-05-01

PhasePHASE4

Conditions

HIV Preventionunresolved

Interventions

Text MessagingBEHAVIORAL

Adherence CounselingBEHAVIORAL

Daily Oral PrEPDRUG

Sponsors & collaborators

University of California, Los Angeleslead sponsor

University of California, San Diegocollaborator

California HIV/AIDS Research Programcollaborator

Los Angeles County Department of Public Healthcollaborator

AIDS Project Los Angelescollaborator

Mapped research locations

Los AngelesCalifornia, United States4 San DiegoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02584140 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.